Saraux, A., Berthelot, J., Le Goff, P., & Youinou, P. (2003). Ability of second-generation anti-cyclic citrullinated peptide (CCP) to predict rheumatoid arthritis in patients with early arthritis. BioMed Central.
استشهاد بنمط شيكاغوSaraux, A., JM Berthelot, P. Le Goff, و P. Youinou. Ability of Second-generation Anti-cyclic Citrullinated Peptide (CCP) to Predict Rheumatoid Arthritis in Patients With Early Arthritis. BioMed Central, 2003.
MLA استشهادSaraux, A., JM Berthelot, P. Le Goff, و P. Youinou. Ability of Second-generation Anti-cyclic Citrullinated Peptide (CCP) to Predict Rheumatoid Arthritis in Patients With Early Arthritis. BioMed Central, 2003.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.